Daniella Mehalik
Director Financiero/CFO en PSYCHEMEDICS CORPORATION .
Cargos activos de Daniella Mehalik
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PSYCHEMEDICS CORPORATION | Director Financiero/CFO | 27/11/2023 | - |
| Contacto de Relaciones con Inversores | - | - | |
| Treasurer | 27/11/2023 | - |
Historial de carrera de Daniella Mehalik
Antiguos cargos conocidos de Daniella Mehalik.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/01/2021 | 01/01/2023 |
| DxTx Medical, Inc. | Comptroller/Controller/Auditor | 01/01/2019 | 01/01/2021 |
Formación de Daniella Mehalik.
| Carlow University Of | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
Sectorial
| Health Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PSYCHEMEDICS CORPORATION | Health Services |
| Empresas privadas | 2 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
| DxTx Medical, Inc. |
- Bolsa de valores
- Insiders
- Daniella Mehalik
- Experiencia
